Antibody-Drug Conjugates (ADCs) market size is expected to reach USD 20.01 Billion at a steady revenue CAGR of 25.8% in 2028, according to latest analysis by Emergen Research. Increasing prevalence of cancer along with growing geriatric population is driving antibody-drug conjugates market revenue growth. Antibody drug conjugates are used to treat cancer and are safer than other types of cancer therapies.
Antibody-drug conjugates are highly targeted therapies that use biopharmaceutical drugs comprising monoclonal antibodies to target tumor cell specific antigens and extremely potent anti-cancer drugs linked through chemical linker. ADCs are considered a powerful and highly effective class of therapeutic agents used in oncology and hematology. ADC technology is also used outside of cancer-related indications.
ADCs are a targeted approach to deliver medicine and chemotherapy agents to cancer cells. Almost 8.2 million persons die each year due to cancer globally. Increasing prevalence of cancer in countries across the globe has created a rapid incline in demand for ADCs. Market players are collaborating to share resources and product knowledge to enhance effectiveness and efficiency of solutions and offerings and to develop even more advanced and effective drugs and therapies.
Emergen Research has published a novel research report titled, “Global Antibody-Drug Conjugates (ADCs) Market Forecast to 2028”. The report sheds light on the current as well as upcoming market trends. The report offers precise information about pricing, capacity, value, gross revenue, and profit of the market. The primary aim of the report is to offer in depth details about market size, revenue growth and overall market dynamics to readers, stakeholders, companies to strengthen their share in the global Antibody-Drug Conjugates (ADCs) market. It also provides in depth information about key factors, restraints, limitations, challenges along with various market segmentations such as product type, application and regional bifurcation.
We Have Recent Updates of Antibody-Drug Conjugates (ADCs) Market in Sample Copy: https://www.emergenresearch.com/request-sample/754
Report Objective:
The report offers a complete analysis of the global Antibody-Drug Conjugates (ADCs) market with details about each market player including company profile, financial standing, global position, revenue contribution, production and manufacturing capacity, business expansion plans, and new product launches. Key players are strategizing various plans such as M&A acquisition, partnerships, joint ventures, license agreement and collaborations. Oxford BioTherapeutics, Bayer AG, Immunomedics Inc., Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Pfizer Inc., ImmunoGen Inc., AbbVie Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.
The report also offers regional level analysis and market estimation for the regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Emergen Research has segmented the global Antibody-Drug Conjugates market on the basis of technology, application, end-use, and region:
- Technology Outlook (Revenue, USD Billion; 2018–2028)
- Cleavable Linker
- Non-Cleavable Linker
- Application Outlook (Revenue, USD Billion; 2018–2028)
- Leukemia
- Lymphoma
- Brain Tumor
- Ovarian Cancer
- Breast Cancer
- Lung Cancer
- Others
- End-use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals
- Research Institute
- Clinics
To know more about the report @ https://www.emergenresearch.com/industry-report/antibody-drug-conjugates-market
Regional Outlook of Antibody-Drug Conjugates (ADCs) Market:
· North America
o U.S.
o Canada
o Mexico
· Europe
o Germany
o U.K.
o Italy
o France
o BENELUX
o Rest of Europe
· Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of APAC
· Latin America
o Brazil
o Rest of LATAM
· Middle East & Africa
o Saudi Arabia
o U.A.E.
o South Africa
o Rest of MEA
Request a discount on the report @ https://www.emergenresearch.com/request-discount/754
Key point summary of the report:
· The report offers a comprehensive overview of the market size, share, and growth rate in the forecast duration.
· It provides details about current scenario, historical data, giving an accurate market forecast for the coming years.
· The study categorizes the market on the basis of product types, applications, end users, market value and volume, business verticals, and 5 major regions.
· It also offers regional market analysis and forecast for prominent geographies in the sector viz., North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
· Industry supply chain, sourcing strategy, upstream feedstock, and downstream demand analysis has also been undertaken in the research report.
· The study offers a comprehensive understanding of the demand and supply dynamics, including production and consumption rates, and mapping of the overall market.
· The report employs different analytical tools including, SWOT analysis, Porter’s five forces analysis, and pricing analysis, to give precise market information.
Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/754
Thank you for reading the research report. We also offer report customization as per client requirement. Kindly connect with us to know more about the customization feature and our team will offer you the best suited report.
Look Over transcripts provided by Emergen Research
Reproductive Genetics Market https://www.emergenresearch.com/industry-report/reproductive-genetics-market
Hemodynamic Monitoring Devices Market https://www.emergenresearch.com/industry-report/hemodynamic-monitoring-devices-market
Drug Infusion Systems Market https://www.emergenresearch.com/industry-report/drug-infusion-systems-market
Face Mask Market https://www.emergenresearch.com/industry-report/face-mask-market
Blood Collection Market https://www.emergenresearch.com/industry-report/blood-collection-market
